Literature DB >> 33635886

A qualitative investigation of HIV treatment dispensing models and impacts on adherence among people living with HIV who use drugs.

Taylor Fleming1,2, Alexandra B Collins3, Geoff Bardwell1,4, Al Fowler1, Jade Boyd1,4, M J Milloy1,4, Will Small1,3, Ryan McNeil1,5,6.   

Abstract

Antiretroviral therapy (ART) dispensing is strongly associated with treatment adherence. Among illicit drug-using populations, whom experience greater structural barriers to adherence, directly administered antiretroviral therapy (DAAT) is often regarded as a stronger predictor of optimal adherence over self-administered medications. In Vancouver, Canada, people living with HIV (PLHIV) who use drugs and live in low-income housing are a critical population for treatment support. This group is typically able to access two key DAAT models, daily delivery and daily pickup, in addition to ART self-administration. This ethno-epidemiological qualitative study explores how key dispensing models impact ART adherence among PLHIV who use drugs living in low-income housing, and how this is framed by structural vulnerability. Semi-structured interviews lasting 30-45 minutes were conducted between February and May 2018 with 31 PLHIV who use drugs recruited from an ongoing prospective cohort of PLHIV who use drugs. Interviews were audio-recorded, transcribed verbatim, and analyzed using QSR International's NVivo 12 software. Interviews focused on housing, drug use, and HIV management. Models that constrained agency were found to have negative impacts on adherence and quality of life. Treatment interruptions were framed by structural vulnerabilities (e.g., housing vulnerability) that impacted ability to maintain adherence under certain dispensing models, and led participants to consider other models. Participants using DAAT models which accounted for their structural vulnerabilities (e.g., mobility issues, housing instability), credited these models for their treatment adherence, but also acknowledged factors that constrained agency, and the negative impacts this could have on both adherence, and quality of life. Being able to integrate ART into an established routine is key to supporting ART adherence. ART models that account for the structural vulnerability of PLHIV who use drugs and live in low-income housing are necessary and housing-based supports could be critical, but the impacts of such models on agency must be considered to ensure optimal adherence.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33635886      PMCID: PMC7909635          DOI: 10.1371/journal.pone.0246999

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


  46 in total

1.  Homelessness as a structural barrier to effective antiretroviral therapy among HIV-seropositive illicit drug users in a Canadian setting.

Authors:  M-J Milloy; Thomas Kerr; David R Bangsberg; Jane Buxton; Surita Parashar; Silvia Guillemi; Julio Montaner; Evan Wood
Journal:  AIDS Patient Care STDS       Date:  2011-11-22       Impact factor: 5.078

2.  Negotiating structural vulnerability following regulatory changes to a provincial methadone program in Vancouver, Canada: A qualitative study.

Authors:  Ryan McNeil; Thomas Kerr; Solanna Anderson; Lisa Maher; Chereece Keewatin; M J Milloy; Evan Wood; Will Small
Journal:  Soc Sci Med       Date:  2015-04-07       Impact factor: 4.634

3.  Independence or autonomy: which is the goal?

Authors:  Wynne S Korr; John A Encandela; Donald Brieland
Journal:  Int J Law Psychiatry       Date:  2005 May-Jun

4.  AIDS incidence and AIDS-related mortality in British Columbia, Canada, between 1981 and 2013: a retrospective study.

Authors:  Viviane D Lima; Lillian Lourenço; Benita Yip; Robert S Hogg; Peter Phillips; Julio S G Montaner
Journal:  Lancet HIV       Date:  2015-03       Impact factor: 12.767

Review 5.  Integrated opioid substitution therapy and HIV care: a qualitative systematic review and synthesis of client and provider experiences.

Authors:  Andy Guise; Maureen Seguin; Gitau Mburu; Susie McLean; Pippa Grenfell; Zahed Islam; Sergii Filippovych; Happy Assan; Andrea Low; Peter Vickerman; Tim Rhodes
Journal:  AIDS Care       Date:  2017-03-10

Review 6.  Housing status and the health of people living with HIV/AIDS.

Authors:  M-J Milloy; Brandon D L Marshall; Julio Montaner; Evan Wood
Journal:  Curr HIV/AIDS Rep       Date:  2012-12       Impact factor: 5.071

7.  Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men.

Authors:  C J Reback; S Larkins; S Shoptaw
Journal:  AIDS Care       Date:  2003-12

Review 8.  Needle exchange and the HIV epidemic in Vancouver: lessons learned from 15 years of research.

Authors:  Elaine Hyshka; Steffanie Strathdee; Evan Wood; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2012-05-11

Review 9.  A historical review of HIV prevention and care initiatives in British Columbia, Canada: 1996-2015.

Authors:  Michelle Olding; Ben Enns; Dimitra Panagiotoglou; Jean Shoveller; P Richard Harrigan; Rolando Barrios; Thomas Kerr; Julio S G Montaner; Bohdan Nosyk
Journal:  J Int AIDS Soc       Date:  2017-09-19       Impact factor: 5.396

10.  Expansion of HAART coverage is associated with sustained decreases in HIV/AIDS morbidity, mortality and HIV transmission: the "HIV Treatment as Prevention" experience in a Canadian setting.

Authors:  Julio S G Montaner; Viviane D Lima; P Richard Harrigan; Lillian Lourenço; Benita Yip; Bohdan Nosyk; Evan Wood; Thomas Kerr; Kate Shannon; David Moore; Robert S Hogg; Rolando Barrios; Mark Gilbert; Mel Krajden; Reka Gustafson; Patricia Daly; Perry Kendall
Journal:  PLoS One       Date:  2014-02-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.